1CM Inc (TSE:EPIC)
:EPIC
Top Page
1CM Inc
(EPIC)
Select Model
Select Model
Rating:54Neutral
Price Target:
C$0.16
▲(1.88% Upside)
Action:ReiteratedDate:02/04/26
The score is supported by strong recent revenue growth and a relatively low-leverage balance sheet, but is held back by compressed, very thin margins and weak free-cash-flow conversion. Technicals are also soft (negative MACD and below key longer-term moving averages), while valuation is not compelling given the ~33 P/E and lack of dividend support.
Positive Factors
Strong Revenue Growth
Sustained ~223% TTM revenue growth signals durable demand expansion and successful commercial traction. A rapidly growing top line provides operating leverage potential, funds incremental R&D and capacity, and creates optionality for product mix improvements over the next several quarters.
Negative Factors
Very Thin Margins
Extremely low gross and net margins leave earnings highly sensitive to input costs, pricing pressure, and manufacturing inefficiencies. Margin compression versus 2024 suggests limited pricing power and structural cost challenges that can cap sustainable profitability over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained ~223% TTM revenue growth signals durable demand expansion and successful commercial traction. A rapidly growing top line provides operating leverage potential, funds incremental R&D and capacity, and creates optionality for product mix improvements over the next several quarters.
Read all positive factors
1CM Inc (EPIC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$20.60M
Dividend YieldN/A
Average Volume (3M)106.00
Price to Earnings (P/E)10.4
Beta (1Y)1.02
Revenue Growth34.71%
EPS GrowthN/A
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding117,736,940
10 Day Avg. Volume200
30 Day Avg. Volume106
Financial Highlights & Ratios
PEG Ratio-2.70
Price to Book (P/B)0.96
Price to Sales (P/S)0.38
P/FCF Ratio11.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
1CM Inc Business Overview & Revenue Model
Company Description
1CM Inc. operates as a multidimensional cannabis company. It focuses on retail customers and technology to democratize cannabis markets. The company was formerly known as Leviathan Natural Products Inc. and changed its name to 1CM Inc. in Septembe...
How the Company Makes Money
null...
1CM Inc Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
72
Positive
Cash Flow
48
Neutral
| Breakdown | Nov 2025 | Nov 2024 | Aug 2023 | Nov 2022 | Aug 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 73.37M | 57.22M | 35.34M | 842.49K | 341.81K |
| Gross Profit | 6.65M | 11.18M | 7.61M | -428.00K | -148.00K |
| EBITDA | 2.88M | 2.86M | 1.31M | -3.36M | -3.57M |
| Net Income | 484.85K | 615.91K | -914.00K | -4.73M | -4.56M |
Balance Sheet | |||||
| Total Assets | 43.52M | 39.87M | 34.02M | 28.23M | 9.32M |
| Cash, Cash Equivalents and Short-Term Investments | 6.15M | 4.97M | 3.08M | 2.24M | 162.46K |
| Total Debt | 3.42M | 7.85M | 6.39M | 11.13M | 12.26M |
| Total Liabilities | 14.65M | 12.14M | 9.42M | 12.85M | 13.78M |
| Stockholders Equity | 28.87M | 27.73M | 24.60M | 15.38M | -3.85M |
Cash Flow | |||||
| Free Cash Flow | 2.51M | 762.99K | -4.37M | -2.75M | -2.01M |
| Operating Cash Flow | 2.71M | 2.47M | -1.75M | -2.53M | -1.99M |
| Investing Cash Flow | -627.84K | -1.71M | 1.33M | 1.75M | -150.80K |
| Financing Cash Flow | -1.57M | 1.13M | 1.26M | 2.85M | 2.30M |
1CM Inc Technical Analysis
Neutral
0.16
Price Trends
0.18
Negative
0.20
Negative
0.25
Negative
Market Momentum
>-0.01
Negative
50.82
Neutral
79.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:EPIC, the sentiment is Neutral. The current price of 0.16 is below the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.18, and below the 200-day MA of 0.25, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.82 is Neutral, neither overbought nor oversold. The STOCH value of 79.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:EPIC.
1CM Inc Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$33.59M | 29.79 | 7.78% | ― | 28.55% | ― | |
54 Neutral | C$20.60M | 10.42 | 2.21% | ― | 34.71% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | C$18.85M | -5.08 | -68.32% | ― | 2.41% | 74.61% | |
45 Neutral | C$27.35M | -3.68 | -19.10% | ― | 18.06% | 34.58% | |
45 Neutral | C$8.46M | 5.19 | ― | ― | 15.64% | 58.47% | |
41 Neutral | C$22.58M | -44.16 | -2.15% | ― | 19.66% | 84.34% |
* Healthcare Sector Average
TSE:EPIC
1CM Inc
0.18
-0.04
-16.67%
TSE:LABS
MediPharm Labs
0.07
-0.03
-31.58%
TSE:PCLO
PharmaCielo
0.06
>-0.01
-8.33%
TSE:ROMJ
Rubicon Organics
0.50
-0.03
-5.66%
TSE:AVCN
Avicanna
0.15
-0.10
-40.00%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.17
-0.03
-15.00%
1CM Inc Corporate Events
Business Operations and StrategyExecutive/Board Changes
1CM Inc. Promotes Antony Pramoth to Chief Financial Officer
Positive
Jan 7, 2026
1CM Inc. has appointed internal candidate Antony Pramoth as its new Chief Financial Officer, replacing former CFO Harshil Chovatiya with immediate effect. The promotion of Pramoth, who has been with the company since October 2023, signals a contin...
Business Operations and StrategyM&A Transactions
SNDL Closes First Tranche of Cannabis Store Acquisition from 1CM
Positive
Jan 7, 2026
SNDL Inc. has completed the acquisition of five cannabis retail stores in Alberta and Saskatchewan from 1CM Inc., marking the first closing under an amended arrangement agreement between the two companies. A second and final closing, covering an a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.